Ferozsons Laboratories : Financial Results for the Quarter Ended 30-09-2023

Ferozsons Laboratories Limited

Condensed Interim Unconsolidated Statement of Profit or Loss (Un-audited)

For the period ended 30 September 2023

	First Quarter ended
	30 September	30 September
	2023	2022
	---------------------- Rupees ---------------------
Revenue - net	3,622,967,251	2,286,494,656
Cost of sales	(2,285,673,006)	(1,292,816,834)
Gross profit	1,337,294,245	993,677,822
Administrative expenses	(191,126,841)	(152,262,244)
Selling and distribution expenses	(781,145,523)	(560,879,547)
Other expenses	(25,797,280)	(147,687,629)
Other income	44,070,494	44,622,436
Profit from operations	383,295,095	177,470,838
Finance cost	(79,667,259)	(20,377,337)
Profit before taxation	303,627,836	157,093,501
Taxation	(123,111,872)	(52,175,930)
Profit after taxation	180,515,964	104,917,571
Earnings per share - basic and diluted
4.15	2.41

Ferozsons Laboratories Limited

Condensed Interim Consolidated Statement of Profit or Loss (Un-audited)

For the period ended 30 September 2023

	First Quarter ended
	30 September		30 September
	2023	2022
	---------------------- Rupees ----------------------
Revenue - net	4,428,541,177	2,566,996,821
Cost of sales	(2,709,194,520)	(1,489,924,570)
Gross profit	1,719,346,657		1,077,072,251
Administrative expenses	(204,410,993)	(171,584,475)
Selling and distribution expenses	(964,464,329)	(611,189,254)
Other expenses	(40,189,050)	(144,245,078)
Other income	77,003,910	74,642,779
Profit from operations	587,286,195		224,696,223
Finance cost	(121,072,697)	(34,670,058)
Profit before taxation	466,213,498		190,026,165
Taxation	(184,744,854)	(57,831,868)
Profit after taxation	281,468,644		132,194,297
Attributable to:
Owners of the Group	263,100,054	126,334,743
Non-controlling interests	18,368,590	5,859,554
Profit after taxation	281,468,644		132,194,297
Earnings per share - basic and diluted	6.05	2.91